Document:

Award Agreements between the Registrant and Gregg C. Fergus

 Exhibit 10.35 
 NIMBLEGEN SYSTEMS, INC. 
 AWARD AGREEMENT 
 This Award Agreement, entered into as of March 6, 2007 (the date of grant), is between NimbleGen Systems, Inc., a Delaware corporation (the
“Company”), and Gregg C. Fergus (the “Participant”). All terms used herein and not otherwise defined shall have the same meaning as set forth in the Company’s 2000 Stock Option and Restricted Stock Plan, as amended and
restated as of September 25, 2001 and as further amended (the “Plan”). 
 WITNESSETH: 
 WHEREAS, the Board of Directors of the Company (the “Board”) desires to induce the Participant to provide services to the Company as one
of its directors, to provide the Participant with a stronger incentive to strive for the continued success and growth of the Company and its Subsidiaries and to further align the Participant’s interests with those of the Company’s
stockholders. 
 NOW THEREFORE, in consideration of the benefits that the Company expects to be derived in connection with the
services to be hereafter rendered by the Participant, the Company and the Participant hereby agree as follows: 
 ARTICLE I

 Award of Option for Restricted Stock 
 1.1. Option; Number of Shares; Option Price. The Participant is granted the right and option to purchase (the “Option”) all or any part of an aggregate of 25,000 shares of the Company’s Common
Stock (individually, a “Share” and jointly, the “Shares”) at the purchase price of $2.174 per Share (the “Option Price”) any time before the tenth anniversary of the date of this Award Agreement. If the Participant
exercises the Option prior to the third anniversary of the date of this Award Agreement, the shares of Common Stock received from the exercise of the Option that are unvested shares according to the schedule set forth in Section 1.2 are
hereafter referred to as “Restricted Shares” and Shares that have vested are referred to as “Vested Shares.” The period during which there are Restricted Shares outstanding is referred to herein as the “Restricted
Period.” If the Option remains outstanding and is exercised on or after the fourth anniversary of the date of this Award Agreement, all of the Shares will be Vested Shares and none of the Shares will be Restricted Shares. 
 1.2. Vesting of Restricted Shares. The vesting schedule for the Shares governed by this Option is as follows. Except as otherwise provided in the
Plan and this Section 1.2, and subject to Section 1.4, the Option will vest as to 1/12th of the Shares on April 1, 2007, and an additional 1/12th of the Shares will vest as of each July 1, October 1, January 1 and
April 1 thereafter, provided that the Participant is still serving as a director of the Company on each vesting date. Notwithstanding the foregoing, the Option will become fully vested upon the occurrence of a Change in Control while the
Participant is still serving as a director of the Company. Shares governed by this Option vest according to this schedule, whether or not the Option has been exercised. 

 1.3. Exercisability of Option. 
 (a) This Option is immediately exercisable and shall expire in accordance with this Section 1.3 and the Plan, but in all events, and
notwithstanding anything herein to the contrary, on the tenth anniversary of the date of this Award Agreement. 
 (b) If the
Participant’s service as a director of the Company terminates, the Option, to the extent not exercised, shall terminate three (3) months after termination of such service with the Company. 
 1.4. Method of Exercising Option. The Option may be exercised in whole or in part by delivery to the Company, at its offices in Madison,
Wisconsin, of (a) written notice identifying the Option and stating the number of Shares with respect to which it is being exercised, in the form attached hereto as Exhibit A, (b) payment in full of the Option Price of the
Shares then being acquired in the form permitted by Section 8 of the Plan, (c) execution of a stockholder agreement substantially in the form attached hereto as Exhibit B (“Stockholder Agreement”), (d) execution
of an Investment Representation Statement in the form attached hereto as Exhibit C if the Shares covered by the Option have not been registered under the Securities Act of 1933, as amended, at the time of the exercise and (e) if the
Option is exercised during the Restricted Period as defined in Section 1.1, a blank stock power for the Restricted Shares. The Company shall have the right to delay the issue or delivery of any Shares to be delivered hereunder until
(i) the completion of such registration or qualification of such Shares under any federal, state or foreign law, ruling or regulation as the Company shall deem to be necessary or advisable, and (ii) receipt from the Participant of such
documents and information as the Company may deem necessary or appropriate in connection with such registration or qualification or the issuance of Shares hereunder. 
 1.5. Prohibitions Against Transfer. The Option, and the rights and privileges conferred hereby, may not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) by
the Participant, or be subject to execution, attachment or similar process, and shall be exercisable only by the Participant, except as provided in Section 12 of the Plan. 
 ARTICLE II 
 Provisions Governing Restricted Shares 
 2.1. Stockholder Status. Prior to the vesting of the Restricted Shares, the Participant shall not have the right to vote the Restricted Shares,
and instead, the Restricted Shares shall be voted as directed by action of the Board. The Participant agrees to execute a proxy upon request of the Board at any time during the Restricted Period appointing an agent designated by the Board to vote
the Restricted Shares. The Participant shall have the right to receive and retain all regular cash dividends paid or distributed in respect of the Restricted Shares, if any, and except as expressly provided otherwise herein, shall have all other
rights as a holder of outstanding shares of Common Stock. Until all of the Restricted Shares vest pursuant to Section 1.2, the Company shall retain custody of the stock certificates representing the Shares unless the Participant requests in
writing that the Company issue a certificate for any portion that represents Vested Shares to the Participant. As soon as practicable after the lapse of the restrictions, the Company shall issue or release or cause to be issued or released
certificate(s) representing the Shares. 
  

 2 

 2.2. Prohibition Against Transfer. Restricted Shares may not be transferred, assigned, pledged or
hypothecated in any way (whether by operation of law or otherwise) by the Participant, or be subject to execution, attachment or similar process. Notwithstanding the foregoing, Restricted Shares may be transferred as the result of any merger,
consolidation, or share exchange involving the Company, in which event the shares received in exchange for the Shares will remain subject to this Award Agreement and treated as “Restricted Shares” hereunder. Any transfer in violation of
this Section 2.2 shall be void and of no further effect. After the Restricted Shares vest, they shall continue to be subject to the limitations on transfer contained in the Stockholder Agreement. 
 2.3. Repurchase of Restricted Shares. If the Participant’s service as a director of the Company terminates for any reason, the Company
shall have the right, but not the obligation, to purchase all or any portion of the Restricted Shares owned by the Participant. Such option shall be exercisable by the Company within six (6) months following the date of such termination of such
service by the Participant by delivery of a written notice to the Participant. The Company may assign its rights under this Section 2.3 to the stockholders of the Company (other than the Participant), at any time, on a pro rata basis. The
purchase price per share of all purchases under this Section 2.3 of Restricted Shares shall be the Option Price. 
 2.4. Payment of
Purchase Price. In the event of the purchase by the Company of Shares under Section 2.3, above, the Company, shall, within thirty (30) days of the delivery to the Participant of the notice that the Company is exercising the option to
purchase Shares, pay the purchase price in cash and shall have the option to evidence that amount of the purchase price that exceeds $10,000 by a promissory note of the Company, dated the day of purchase by the Company (the “Promissory
Note”). The Promissory Note shall be payable in four (4) equal annual installments, commencing on the Closing Date, as defined in Section 2.5, below, with each subsequent installment to be due on the anniversary date of the Closing
Date each year thereafter. Interest on the deferred balance of the purchase price shall accrue from the Closing Date at the Annual Mid-Term Federal Rate published by the Internal Revenue Service as of the end of the month preceding or coincident
with the purchase and shall be payable with each installment of principal. The Company shall have the right to prepay the deferred balance at any time, without penalty. All payments shall be applied first to interest which is accrued and unpaid and
then to principal. Any promissory note issued hereunder shall provide that all sums not yet due and payable thereunder shall be and become immediately due and payable upon any Change in Control. The parties may, by written agreement, alter or modify
the payment schedule provided herein. 
 2.5. Closing Date. The closing date (the “Closing Date”) for the purchase of any
Shares pursuant to Section 2.3, above, shall be the date the Shares are endorsed and delivered to the Company and the Company has tendered to the Participant the consideration required by this Award Agreement, including, without limitation, any
cash then due and any Promissory Note evidencing the obligations of the Company to the Participant. The Closing Date shall occur on the business day designated by the Company, but not later than seven (7) months after the Participant’s
termination of service as a director of the Company. The Participant agrees to use best efforts to cause all transactions required to be consummated hereunder to be closed as provided herein and acknowledges that time is of the essence. 

 

 3 

 ARTICLE III 
 Miscellaneous 
 3.1. Provisions of the Plan Control. This Award Agreement shall be
governed by the provisions of the Plan, the terms and conditions of which are incorporated herein by reference. In the event that the provisions of this Award Agreement and the Plan conflict, the Plan shall control. The Plan empowers the
Administrator to make interpretations, rules and regulations thereunder, and, in general, provides that determinations of the Administrator with respect to the Plan shall be binding upon the Participant. A copy of the Plan will be delivered to the
Participant upon reasonable request. 
 3.2. Taxes. The Company may require payment or reimbursement of or may withhold any tax that
it believes is required as a result of the exercise of the Option or issuance of shares, and the Company may defer making delivery with respect to Shares for which the Option was exercised or with respect to Vested Shares which previously had been
Restricted Shares until arrangements satisfactory to the Company have been made with respect to such withholding obligations. 
 3.3. Tax
Consequences. The Participant understands that the Participant may suffer adverse tax consequences as a result of the Participant’s purchase or disposition of the Shares. The Participant represents that the Participant will consult with any
tax consultants the Participant deems advisable in connection with the purchase and disposition of the Shares. 
 3.4. Notices. Any
notice to be given to the Company under the terms of this Award Agreement shall be given in writing to the Company in care of its then principal executive officer at its then principal place of business. Any notice to be given to the Participant may
be addressed to him at his address as it appears on the payroll or other records of the Company or any affiliate thereof. Any such notice will be deemed to have been duly given: (a) upon personal delivery to the party to be notified,
(b) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt at the Participant’s or the Company’s address. 
 3.5. Governing Law. This Award Agreement and all questions arising hereunder or in connection herewith shall be determined in accordance with the
laws of the State of Wisconsin, without giving effect to the principles of conflicts of laws. 
 3.6. No Right to Continued Service.
This Award Agreement shall not confer upon the Participant any right with respect to continuation of service on the Board or any committee thereof, nor shall it interfere in any way with the right of the Company to terminate the Participant’s
service on the Board or any committee thereof at any time. 
  

 4 

 3.7. Multiple Copies. One or more copies of this Award Agreement may be executed, each of which
will be deemed an original, but all of which together will constitute one and the same agreement. 
 IN WITNESS WHEREOF, the Company
has caused this Award Agreement to be executed as of the date and year first above written, which is the date of the granting of the Option evidenced hereby. 
  

			
	 NIMBLEGEN SYSTEMS, INC.

		
	 By:
	 	 /s/ Thomas M. Palay

		 	Thomas M. Palay,
		 	 Vice-Chairman of the Board of Directors and
 Vice
President

 The undersigned Participant hereby accepts the foregoing Option and agrees to the several
terms and conditions hereof and of the Plan. 
  

	
	Participant:
	
	 /s/ Gregg C. Fergus

	Gregg C. Fergus

  

 5 

 Spousal Consent and Acknowledgment 
 I acknowledge that I have read the Award Agreement and the Stockholder Agreement, attached thereto as Exhibit B, and that I understand their
contents. I am aware that by their provisions my spouse agrees, among other things, to limit the transferability of and the voting rights attendant upon his or her Shares of NimbleGen Systems, Inc. which may be acquired through his or her exercise
of an Option. I am further aware that the terms and limitations set forth in such agreements shall apply to any interest I have in the Option or the Shares (including without limitation any right or interest by operation of the Wisconsin Marital
Property Law, chapter 766 of the Wisconsin Statutes, or by operation of any other law) and the interest of any of my heirs, legatees, or other transferees. I consent to and approve the provisions of the Award Agreement and the Stockholder Agreement,
and agree that the Option and the Shares and my interest in them are subject to the provisions of such Agreements, and direct the personal representative of my estate to promptly comply with all of the provisions of such Agreements. I further agree
that I will take no action at any time to hinder the operation of the Award Agreement or the Stockholder Agreement as to the Option and/or the Shares or any interest that I or my transferees have in them. 
  

							
	 Date:
	 	  
	 	Spouse:	 	  

 EXHIBIT A 
 NIMBLEGEN SYSTEMS INC. 2000 STOCK OPTION 
 AND RESTRICTED STOCK PLAN 
 EXERCISE NOTICE 
 1. Exercise of
Option. Effective as of today,
                                        ,
20    , the undersigned (the “Participant”) hereby elects to exercise the Participant’s option to purchase
                     shares of the Common Stock (the “Shares”) of NimbleGen Systems, Inc. (the “Company”) under and
pursuant to the Company’s 2000 Stock Option and Restricted Stock Plan, as amended and restated as of September 25, 2001 and as further amended (the “Plan”), and the Award Agreement dated as of March 6, 2007 (the “Award
Agreement”). All terms used herein and not otherwise defined shall have the meaning set forth in the Plan, the Award Agreement, or in the form of stockholder agreement that is attached to the Award Agreement as Exhibit B (the “Stockholder
Agreement”). 
 2. Representations of the Participant. The Participant acknowledges that the Participant has received, read and
understands the Plan, the Award Agreement, and the Stockholder Agreement and agrees to abide by and be bound by their terms and conditions. 
 3. Rights as Stockholder. Until the stock certificate evidencing such Shares is issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) and the Stockholder
Agreement is executed by the Participant, no right to vote or receive dividends or any other rights as a Stockholder shall exist with respect to the Shares, notwithstanding the exercise of the Option. The Company shall issue (or cause to be issued)
such stock certificate promptly after the Option is exercised, subject to the terms of the Award Agreement. 
 The Participant shall enjoy
rights as a Stockholder, subject to his Award Agreement and the Stockholder Agreement, until such time as the Participant disposes of the Shares or the Company and/or its assignee exercises its rights under Section 3.2 of the Stockholder
Agreement or Section 2.3 of the Award Agreement. Upon such exercise, the Participant shall have no further rights as a holder of the Shares so purchased except the right to receive payment for the Shares so purchased in accordance with the
provisions of the Stockholder Agreement and/or the Award Agreement, and the Participant shall forthwith cause the certificate(s) evidencing the Shares so purchased to be surrendered to the Company for transfer or cancellation. 
 4. Delivery of Payment. The Participant delivers to the Company with this Exercise Notice payment of the Option Price for the Shares. 

5. Interpretation. Any dispute regarding the interpretation of this Exercise Notice shall be submitted by the Participant or by the Company
forthwith to the Administrator of the Plan, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be final and binding on all persons. 

 6. Governing Law; Severability. This Exercise Notice shall be governed by and construed in
accordance with the laws of the State of Wisconsin excluding that body of law pertaining to conflicts of law. Should any provision of this Exercise Notice be determined by a court of law to be illegal or unenforceable, the other provisions shall
nevertheless remain effective and shall remain enforceable. 
 7. Notices. Any notice to the Company permitted or required hereunder
shall be given in writing to the Company in care of its then President at its then principal place of business. Any notice to be given to the Participant may be addressed to him at his address as it appears on the payroll or other records of the
Company or any affiliate thereof. Any such notice will be deemed to have been duly given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed facsimile if sent during normal business hours of the recipient,
if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight
courier, specifying next day delivery, with written verification of receipt at the Participant’s or the Company’s address. 
 8.
Further Instruments. The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to carry out the purposes and intent of this agreement. 
  

							
	 Participant:
	 	Accepted by:
		 	NIMBLEGEN SYSTEMS, INC.
			
	  
	 	By:	 	  

	 Print name:
	 	  
	 	Its:	 	  

  

 A-2 

 EXHIBIT B 
 FORM OF 
 STOCKHOLDER AGREEMENT 
 WITH 
 NIMBLEGEN SYSTEMS, INC. 
 (Applicable to Shares Purchased By Exercise of Stock Options) 
 This Stockholder Agreement (the “Agreement”) dated as of this ___ day of _________, _______, is by and between NimbleGen Systems, Inc., a Delaware corporation (the “Company”), and the person whose
name appears on the signature page hereof (the “Participant”). 
 RECITALS 
 The Company granted the Participant an option (the “Option”) to purchase shares of the Company’s Common Stock pursuant to its 2000 Stock
Option and Restricted Stock Plan, as amended and restated as of September 25, 2001 and as further amended. The Company and the Participant entered into that certain Award Agreement dated March 6, 2007 (the “Award Agreement”)
setting out the terms of such option grant. The Participant has purchased                      shares of the Company’s Common Stock
pursuant to the Award Agreement, which, together with all other such shares from time to time purchased by the Participant pursuant to the Award Agreement, including those shares purchased after the date of this Agreement, are the “Shares”
hereunder. 
 The Company made its grant of the Option on certain terms and conditions including the requirement that the Participant and the
Company would enter into this Agreement as a condition to the right to exercise the Option. 
 In consideration of the mutual promises herein
contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 1.1. Certain Definitions. For purposes of this Agreement, the following terms shall have the meanings set forth below; all other capitalized terms shall have the meanings set forth elsewhere in this Agreement:

 “Affiliate” means (i) any person directly or indirectly controlled by a holder of capital stock of the Company, in
control of a holder of capital stock of the Company, or under common control with a holder of capital stock of the Company, (ii) any member, partner, subsidiary, officer, director or stockholder of a person or entity referred to in clause (i),
and (iii) any other person or entity directly or indirectly in control of or under the control of any person or entity referred to in clause (ii). “Controlled,” “controlled by,” and “under common control with”
shall 

 
mean direct or indirect possession of the power to direct or cause the direction of management or policies (whether through ownership of voting securities,
by contract or otherwise) of a person; provided, that common control shall be conclusively presumed between or among an individual and members of the immediate family (spouse, siblings, ancestors, descendants or the spouse of any of the foregoing)
of such individual, an individual and a trust primarily for the benefit of such individual, or an immediate family member of such individual. 
 “Common Stock” means shares of the Company’s common stock, $.001 par value. 
 “Permitted
Transfer” has the meaning set forth in Section 2.2. 
 “Restricted Shares” has the meaning given in the Award
Agreement. 
 “Share(s)” has the meaning set forth in the Recitals. 
 “Stockholder” means any person who holds legal title to any issued and outstanding share of the Company’s Common Stock or preferred
stock, and any stock into which any such class of stock is converted or exchanged. 
 “Transfer” or
“Transfers” means, with respect to the Shares, any sale, pledge, hypothecation, gift, devise, distribution, or other disposition of Shares, including, but not limited to, any direct or indirect change in legal or beneficial
ownership effected by any voluntary or involuntary disposition of Shares or by operation of law or by legal or equitable process. 
 “Vested Shares” has the meaning given in the Award Agreement. 
 ARTICLE II 
 RESTRICTIONS ON TRANSFER 
 2.1.
General Restriction. No Transfer of the Shares may be made by the Participant (including, without limitation, an executor or personal representative, guardian, or conservator of the Participant), except pursuant to the terms of the Award
Agreement, this Agreement, and in accordance with the terms of the Bylaws of the Company. Any Transfer of Shares which violates the terms of the Award Agreement or this Agreement shall be voidable by the Company, and neither the Company nor its
transfer agent shall permit such transfer to be made on the stock records of the Company. 
 2.2. Permitted Transfers. The prohibition
of Section 2.1 shall not apply to any Transfer of any interest in the Participant’s Shares, provided however that this Section 2.2 does not apply to Restricted Shares, (i) to his/her spouse or lineal descendant (hereafter
“Immediate Family”) or a trust for the benefit of his/her Immediate Family, provided that the Participant retains the right to vote any Shares so transferred; (ii) upon the Participant’s death; (iii) as the result of any
merger, consolidation, or share exchange involving the Company; (iv) any exchange of existing Shares for other shares of the same or a different class or series in the Company, whether through the exercise of conversion rights or otherwise; or
(v) to the Company (hereinafter a “Permitted 

  

 B-2 

 
Transfer”). The foregoing notwithstanding, a Transfer of Shares may not be made to a transferee described in clauses (i) or (ii) of the
preceding sentence unless the transferee agrees to be bound by the terms of this Agreement applicable to Vested Shares, and in the case of a Transfer described in clauses (iii) and (iv), the shares received in exchange for the Shares will
remain subject to this Agreement and treated as “Shares” hereunder. 
 ARTICLE III 
 TRANSFER OF STOCK – GENERAL 
 3.1. Third Party Offers. If the Participant receives a bona fide written offer (“Offer”) from a third party to purchase some or all of the Vested Shares registered in his name and the Participant desires to accept that
offer (except for a Permitted Transfer), the Participant shall give written notice to the Company (the “Sale Notice”) of his desire to transfer such Vested Shares and, in that event, the Company shall have the rights granted herein.

 3.2. Company Option. The Company shall have an option to purchase all or any portion of the Vested Shares which are the subject of
a Sale Notice at the lesser of the price specified in the Offer or Fair Market Value, as determined under Section 3.5, and on the terms specified in Sections 3.6 and 3.7. The Company shall have thirty (30) days after delivery of the
Sale Notice to exercise its option (the “Company Option Period”). This option may be exercised by giving written notice of exercise (the “Exercise Notice”) to the Participant during the Company Option Period. Delivery of the
Exercise Notice shall obligate the Company to purchase and the Participant to sell the Shares of the Participant identified in the Exercise Notice on the terms provided in this Article III. 
 3.3. Sale to Third Party. If the Company, after receiving the Sale Notice, fails to exercise its option as provided in Section 3.2, or if it
declines to exercise the same, the Participant shall be entitled to transfer the Vested Shares to the third party on the terms contained in the Offer, and shall be entitled to have his Vested Shares transferred on the books of the Company, but only
if the third party purchaser agrees to be bound by the terms of this Agreement applicable to Vested Shares. If the Participant fails to close the transfer of his Vested Shares within sixty (60) days after the option of the Company has expired
or been waived, the restrictions contained in this Article III shall again apply and must be met prior to effecting any transfer of Vested Shares. Any transfer of Vested Shares by the Participant to any unaffiliated third party shall comply with all
applicable securities laws, and the Company may refuse to transfer any Vested Shares unless it receives such assurance and opinions from legal counsel acceptable to the Company that any such transfer is in compliance with all applicable securities
laws. 
 3.4. Drag-Along Rights. 
 (a) If one or more Stockholders (the “Controlling Stockholder”) wishes to sell all or part of the capital stock of the Company owned by the Controlling Stockholder that represents fifty percent (50%) or
more of all the voting power of all classes of stock of the Company then outstanding in one transaction, or a series of related transactions, to a third-party who is not an Affiliate of such Controlling Stockholder (a “Sale 

  

 B-3 

 
Transaction”), such Controlling Stockholder may, in its sole discretion, require the Participant to sell all or the same proportionate amount of Shares
(including Restricted Shares at the Controlling Stockholder’s option, in which case the Shares to be sold will become Vested Shares) as the Controlling Stockholder in accordance with this Section 3.4 (“Drag-Along Rights”). If the
Controlling Stockholder exercises its Drag-Along Rights, the Participant shall be required to sell his/her Shares or a portion of his/her Shares at a purchase price per Share and upon the same terms as the shares of the Controlling Stockholder.

 (b) The Controlling Stockholder who desires to exercise its Drag-Along Rights shall deliver a notice to the Participant and
the Company setting forth the terms of the Sale Transaction (including the proposed closing date for the Sale Transaction), and provide all documents required to be executed by the Participant in order to consummate such Sale Transaction. The
Participant shall deliver to the Controlling Stockholder at least seven (7) business days prior to the proposed closing date referred to above all documents and certificates, correctly endorsed and executed, necessary to close the Sale
Transaction. If the Participant fails to deliver such documents to the Controlling Stockholder, the Company shall cause its books and records to show that the Shares held by the Participant have been transferred pursuant to the provisions of this
Section 3.4. 
 (c) The Controlling Stockholder shall have one hundred twenty (120) days from the date of the notice
described in subsection 3.4(b) above, to consummate any Sale Transaction and, promptly after such consummation, shall notify the Company and the Participant to that effect. The Controlling Stockholder shall also cause to be remitted to the
Participant the proceeds attributable to the sale of the Participant’s Shares not later than three (3) business days after the closing of the Sale Transaction. If any Sale Transaction is not consummated prior to the expiration of the
one-hundred twenty (120) day period referred to in this Section, the Controlling Stockholder may not thereafter consummate the proposed Sale Transaction (without complying again with subsection 3.4(b) above) and shall return to the Participant
all documents previously delivered to the Controlling Stockholder in connection with such Sale Transaction. 
 3.5. Fair Market Value.
For purposes of this Agreement, fair market value shall be determined in good faith by the Board of Directors (the “Fair Market Value”). 
 3.6. Payment of Purchase Price. In the event of the purchase by the Company of Shares under Section 3.2 of this Agreement, the Company, shall, within thirty (30) days of the delivery to the Participant of the notice that
the Company is exercising the option to purchase Shares, pay the purchase price in cash and shall have the option to evidence that amount of the purchase price that exceeds $10,000 by a promissory note of the Company, dated the day of purchase by
the Company (the “Promissory Note”). The Promissory Note shall be payable in four (4) equal annual installments, commencing on the Closing Date, as defined in Section 3.7, below, with each subsequent installment to be due on the
anniversary date of the Closing Date each year thereafter. Interest on the deferred balance of the purchase price shall accrue from the Closing Date at the Annual Mid-Term Federal Rate published by the Internal Revenue Service as of the end of the
month preceding or coincident with the purchase and shall be payable with each 

  

 B-4 

 
installment of principal. The Company shall have the right to prepay the deferred balance at any time, without penalty. All payments shall be applied first
to interest which is accrued and unpaid and then to principal. Any promissory note issued hereunder shall provide that all sums not yet due and payable thereunder shall be and become immediately due and payable upon any Change in Control (as defined
in Section 2(e) of the Plan) of the Company. The parties may, by written agreement, alter or modify the payment schedule provided herein. 
 3.7. Closing. 
 (a) The closing date (the “Closing Date”) for the purchase of any Shares pursuant
to this Article III shall be the date the Shares are endorsed and delivered to the purchaser and the purchaser has tendered to the Participant the consideration required by this Agreement, including, without limitation, any cash then due and any
Promissory Note evidencing the obligations of the purchaser to the Participant. 
 (b) The Closing Date shall occur on the
business day designated by the Company, but not later than sixty (60) days following the delivery of the applicable Exercise Notice described in Section 3.2. The Company and the Participant agree to use best efforts to cause all
transactions required to be consummated hereunder to be closed as provided herein and acknowledge that time is of the essence. 
 ARTICLE
IV 
 STOCK LEGEND 
 All certificates representing Shares now owned or hereafter acquired by a party to this Agreement or their transferee(s) shall bear a legend in substantially the form set forth below: 
 (a) THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS UPON TRANSFER, MANDATORY SALE UPON THE HAPPENING OF
CERTAIN EVENTS, AND VOTING RESTRICTIONS AS SET FORTH IN CERTAIN AGREEMENTS BETWEEN THE ORIGINAL HOLDER OF THE SHARES AND THE COMPANY, COPIES OF WHICH ARE ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY. 
 (b) THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933 OR ANY APPLICABLE STATE SECURITIES LAW. SUCH SHARES MAY NOT BE PLEDGED, SOLD, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE COMPANY REASONABLY ACCEPTABLE TO IT
STATING THAT SUCH PLEDGE, SALE, TRANSFER OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND ANY APPLICABLE STATE SECURITIES LAW. 
  

 B-5 

 ARTICLE V 
 MARKET STAND-OFF AGREEMENT 
 The Participant hereby agrees, if so requested by the managing
underwriters or the Company in connection with an initial public offering of the Company’s Common Stock, that, without the prior written consent of such managing underwriters, the Participant will not offer, sell, contract to sell, grant any
option to purchase, make any short sale or otherwise dispose of, assign any legal or beneficial interest in or make a distribution of any capital stock of the Company held by or on behalf of the Participant or beneficially owned by the Participant
in accordance with the rules and regulations of the Securities and Exchange Commission for a period of up to 180 days after the date of the final prospectus relating to the Company’s initial public offering. 
 ARTICLE VI 
 CERTAIN MARITAL
TRANSFERS 
 The creation or existence of any interest in any Shares which interest is acquired or owned by the spouse or former
spouse of any Stockholder as community or marital property during marriage, as a result of property division or other award or Transfer upon dissolution of the marriage, or as a result of any allowance or assignment of property under any applicable
community or marital property law (a “Marital Transfer”) shall be permitted by, and deemed in compliance with, this Agreement; provided, however, that the following conditions are satisfied: (a) the Shares in which such an interest is
created or exists are and continue to be (1) held of record in the name of such Stockholder and (2) managed and controlled by such Stockholder, and (b) the spouse or former spouse shall have executed a spousal consent and
acknowledgement in the form attached to the Award Agreement. At the first such time when either of the conditions in the foregoing provision cease to be satisfied with respect to any Shares, an Offer shall be deemed to have been given with respect
to such Shares. This Article VI shall not apply to a Permitted Transfer of Vested Shares in accordance with Section 2.2, above. 
 ARTICLE VII 
 GENERAL PROVISIONS 
 7.1. Further Assurances. Subject to the terms and conditions herein provided, each party hereto agrees to use its reasonable efforts to take, or cause to be taken, all actions necessary, proper or
advisable, within applicable laws and regulations to consummate and make effective, as soon as practicable, the transactions contemplated by this Agreement. If at any time before or after the date of this Agreement any further action is reasonably
necessary, proper or advisable to carry out the purposes of this Agreement, as soon as reasonably practicable each party hereto shall at the expense of the requesting party take all such reasonably necessary, proper or advisable action to effectuate
such purposes. 
 7.2. Governing Law; Jurisdiction. The interpretation and construction of this Agreement and the resolution of any
disputes arising out or of in connection with this Agreement or any breach hereof, shall, unless otherwise expressly provided, be governed by and be construed in accordance with the internal law of the State of Wisconsin without regard to the
conflicts of laws principles thereof. 
  

 B-6 

 7.3. Remedies. The parties agree that any breach of this Agreement by any party hereto will cause
the other parties hereto irreparable harm and that damages will not constitute an adequate remedy. Accordingly, the parties agree that injunctive relief, including, without limitation, the issuance of a temporary, preliminary or permanent injunction
is an appropriate and proper remedy for any breach hereof, in addition to any award of damages which may be proven. 
 7.4. Notices.
Any notice to be given to the Company under the terms of this Agreement shall be given in writing to the Company in care of its President at its then principal place of business. Any notice to be given to the Participant may be addressed to him at
his address as it appears on the payroll or other records of the Company or any affiliate thereof. Any such notice will be deemed to have been duly given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed
facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt at the Participant’s or the Company’s address. 
 7.5. Entire Agreement; Amendments. This Agreement, the Award Agreement and the Exercise Notice constitute a complete statement of all of
the arrangements between the parties as of the date hereof with respect to the transactions contemplated hereby, and thereby supersedes all prior agreements and understandings between them with respect thereto and cannot be changed or terminated
orally. 
 7.6. Termination. Sections 2.1, 3.1, 3.2, 3.3, and 3.4 of this Agreement shall terminate and be of no further force or
effect upon the earlier of (a) merger of the Company pursuant to which Stockholders of the Company receive securities of a buyer whose securities are publicly traded; or (b) consummation by the Company of a public offering of its equity
securities pursuant to a registration statement filed with the Securities and Exchange Commission under the Securities Act of 1933. Upon termination of Sections 2.1, 3.1, 3.2, 3.3, and 3.4 of this Agreement, as herein provided, each Stockholder
may deliver the certificates of his or her Shares to the secretary of the Company and have the certificates reissued, without the legend required under this Agreement appropriately modified. 
 7.7. Headings and Defined Terms. The headings in this Agreement are intended solely for convenience of reference and shall be given no effect in
the construction or interpretation of this Agreement. 
 7.8. Recitals. The recitals, first stated above, are an integral part of this
Agreement and are incorporated herein. 
 7.9. Successors. This Agreement shall inure to the benefit of, and be binding upon, the
parties hereto, their heirs, successors and assigns. 
  

 B-7 

 7.10. No Waiver. The failure of a party to insist upon strict adherence to any term of this
Agreement on any occasion shall not be considered a wavier or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement. Any waiver must be in writing. 
 7.11. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be considered an original, but all of which
together shall constitute the same instrument. 
 7.12. Severability. The invalidity of any provision in this Agreement shall not
affect the validity of any other provision. 
 IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year first
above written. 
  

			
	 NIMBLEGEN SYSTEMS, INC.,

	 a Delaware corporation (the “Company”)

		
	 By:
	 	  

	 Its:
	 	  

  

			
	 Participant:

	
	  

	 Print name:
	 	  

  

 B-8 

 EXHIBIT C 
 INVESTMENT REPRESENTATION STATEMENT 
 PARTICIPANT: 
  

	COMPANY:	NIMBLEGEN SYSTEMS, INC. 

  

	SECURITY:	COMMON STOCK 

 AMOUNT: 
 DATE: 
 In connection with the purchase of the above-listed
shares of Common Stock (the “Securities”), the undersigned director (“Participant”) represents to the Company the following: 
 (a) Participant is aware of the Company’s business affairs and financial condition and has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the
Securities. Participant is acquiring these Securities for investment for Participant’s own account only and not with a view to, or for resale in connection with, any “distribution” thereof within the meaning of the Securities Act of
1933, as amended (the “Securities Act”). 
 (b) Participant acknowledges and understands that the Securities
constitute “restricted securities” under the Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of
Participant’s investment intent as expressed herein. In this connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant’s
representation was predicated solely upon a present intention to hold these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the
Securities, or for a period of one year or any other fixed period in the future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such
registration is available. Participant further acknowledges and understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities will be imprinted with a legend
which prohibits the transfer of the Securities unless they are registered or such registration is not required in the opinion of counsel satisfactory to the Company, and any other legend required under applicable state securities laws. 

 (c) Participant is familiar with the provisions of Rule 701 and Rule 144, each
promulgated under the Securities Act, which, in substance, permit limited public resale of “restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain
conditions. Rule 701 provides that if the issuer qualifies under Rule 701 at the time of the grant of the Option to the Participant, the exercise will be exempt from registration under the Securities Act. In the event the Company becomes subject to
the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, ninety (90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt under Rule 701 may be resold,
subject to the satisfaction of certain of the conditions specified by Rule 144, including: (1) the resale being made through a broker in an unsolicited “broker’s transaction” or in transactions directly with a market maker (as
said term is defined under the Securities Exchange Act of 1934); and, in the case of an affiliate, (2) the availability of certain public information about the Company, (3) the amount of Securities being sold during any three month period
not exceeding the limitations specified in Rule 144(e), and (4) the timely filing of a Form 144, if applicable. 
 In the
event that the Company does not qualify under Rule 701 at the time of grant of the Option, then the Securities may be resold in certain limited circumstances subject to the provisions of Rule 144, which requires the resale to occur not less than one
year after the later of the date the Securities were sold by the Company or the date the Securities were sold by an affiliate of the Company, within the meaning of Rule 144; and, in the case of acquisition of the Securities by an affiliate, or by a
non-affiliate who subsequently holds the Securities less than two years, the satisfaction of the conditions set forth in sections (1), (2), (3) and (4) of the paragraph immediately above. 
 (d) Participant further understands that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied,
registration under the Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange
Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 will have a substantial burden of proof in establishing that an
exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant understands that no assurances can be given that any such
other registration exemption will be available in such event. 
  

	
	 Signature of Participant:

	
	  

	 Date:
                                        ,
20    

  

 C-2Form of Indemnification Agreement

 EXHIBIT 10.36 
 INDEMNIFICATION AGREEMENT 
 THIS INDEMNIFICATION AGREEMENT (“Agreement”) is made and
entered into as of the      day of             , 20    , by and between NIMBLEGEN SYSTEMS, INC., a Delaware corporation (the
“Company”), and                      (“Indemnitee”), to become effective in such manner and at such time as
provided herein. 
 WITNESSETH: 
 WHEREAS, the Board of Directors of the Company (the “Board”) is considering a potential initial public offering of the Company’s common stock (the “IPO”); 
 WHEREAS, highly competent persons have become more reluctant to serve as directors and/or executive officers of publicly-held corporations unless they
are provided with adequate protection through insurance and indemnification against risks of claims and actions against them arising out of their service to and activities on behalf of such corporations. 
 WHEREAS, directors and/or executive officers, in connection with the performance of their duties as such, are increasingly being subjected to costly and
time-consuming liabilities and claims relating to, among other things, matters that traditionally would have been brought only against the corporation itself. 
 WHEREAS, the Board has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons
serving the Company and its subsidiaries from certain liabilities. Nevertheless, the Board recognizes the limitations on the protection provided by liability insurance and the uncertainties as to the scope and level of such coverage that may be
available in the future. 
 WHEREAS, the Company’s directors and/or executive officers have certain existing indemnification
arrangements pursuant to the Company’s certificate of incorporation and bylaws and may be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (“DGCL”). Nevertheless, the Board recognizes
the limitations on the protection provided by such indemnification and the uncertainties as to its availability in any particular situation. 
 WHEREAS, the Board believes that in light of the limitations and uncertainties about the protection provided by the Company’s liability insurance and existing indemnification arrangements and the impact these uncertainties may have on
the Company’s ability to attract and retain qualified individuals to serve as directors and/or executive officers, the Company should act to assure such persons that there will be increased certainty of such protection in the future.

 WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be adequately protected. 

 WHEREAS, Indemnitee is concerned that the protection provided under the Company’s liability
insurance and existing indemnification arrangements may not be adequate and may not be willing to serve as a director and/or executive officer of the Company without greater certainty concerning such protection, and the Company desires Indemnitee to
serve in such capacity and is willing to provide such greater certainty. 
 NOW, THEREFORE, in consideration of the promises contained
herein, the Company and Indemnitee do hereby agree as follows: 
 ARTICLE 1 
 DEFINITIONS 
 (a) As used in this Agreement: 
 “Agreement” has the meaning set forth in the preface above. 
 “Board” has the meaning set forth in the recitals above. 
 “Change in Control” shall be deemed to have occurred in any one of the following circumstances occurring after the date hereof: (i) there shall have occurred an event required to be reported with
respect to the Company in response to Item 6(e) of Schedule 14A of Regulation 14A (or in response to any similar item on any similar schedule or form) under the Exchange Act, regardless of whether the Company is then subject to such
reporting requirement; (ii) any “person” or “group” (as such terms are used in Section 13(d) and Section 14(d) of the Exchange Act) shall have become, without prior approval of the Board, the “beneficial
owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding voting securities
(provided that as used in this clause (ii), the term “person” shall exclude a trustee or other fiduciary holding securities under an employee benefit plan of the Company); (iii) there occurs a merger or consolidation of the Company
with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being
converted into voting securities of the surviving or resulting entity) more than fifty percent (50%) of the combined voting power of the voting securities of the surviving or resulting entity outstanding immediately after such merger or
consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving or resulting entity; (iv) all or substantially all the assets of the Company are sold or otherwise disposed of in
a transaction or series of related transactions; (v) the approval by the stockholders of the Company of a complete liquidation of the Company or the sale or other disposition of all or substantially all of the assets of the Company; or
(vi) the individuals who on the date hereof constitute the Board (including, for this purpose, any new director whose election or nomination for election by the Company’s stockholders was approved by a vote of at least a majority of the
directors then still in office who were directors on the date hereof or whose election or nomination was so approved) cease for any reason to constitute at least a majority of the members of the Board. 
  

 2 

 “Company” has the meaning set forth in the preface above. Notwithstanding the foregoing,
references to the “Company” shall include, in addition to the surviving or resulting corporation in any merger or consolidation involving the Company, any constituent corporation (including any constituent of a constituent) absorbed in
such a merger or consolidation which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents, so that if Indemnitee is or was a director, officer, employee or agent of
such constituent corporation or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another Enterprise, then Indemnitee shall stand in the same position under the provisions of this Agreement
with respect to the surviving or resulting corporation as Indemnitee would have with respect to such constituent corporation if its separate existence had continued. 
 “Corporate Status” means the status of a person who is or was a director, officer, employee or agent of the Company or who is or was serving at the request of the Company as a director, officer,
employee or agent of any other Enterprise. 
 “D&O Insurance” has the meaning set forth in Section 7.1(a), below.

 “Delaware Court” has the meaning set forth in Section 8.12, below. 
 “DGCL” has the meaning set forth in the recitals above. 
 “Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification or advancement of Expenses is sought by Indemnitee.

 “Enterprise” means any corporation, limited liability company, partnership, joint venture, trust, employee benefit plan
or other person or enterprise. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 “Expenses” means all costs, expenses and obligations (including, without limitation, fees and expenses of counsel, retainers, court
costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage and delivery service fees) paid or incurred in connection with prosecuting, defending, preparing to
prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. The term “Expenses” shall include expenses incurred in connection with any appeal resulting from any Proceeding,
including, without limitation, the premium, security for and other costs relating to any cost bond, supersedeas bond or other appeal bond or its equivalent. 
 “Good Faith” shall mean Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and with respect to any criminal
action, suit or proceeding, Indemnitee had no reasonable cause to believe Indemnitee’s conduct was unlawful. 
 “IICPR”
has the meaning set forth in Section 6.1(c), below. 
  

 3 

 “Indemnitee” has the meaning set forth in the preface above. 
 “Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporate law and neither currently
is, nor in the five (5) years previous to its selection or appointment has been, retained to represent (i) the Company or Indemnitee in any matter material to either such party (provided that acting as an Independent Counsel under this
Agreement or in a similar capacity with respect to any other indemnification arrangements between the Company and its present or former directors shall not be deemed a representation of the Company or Indemnitee), or (ii) any other party to the
Proceeding giving rise to a claim for indemnification or advancement of Expenses hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any Person who, under the applicable standards of professional
conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. 
 “IPO” has the meaning set forth in the recitals above. 
 “Liabilities” means all judgments, fines (including any excise taxes assessed with respect to any employee benefit plan), penalties and amounts paid in settlement and other liabilities (including all
interest, assessments and other charges paid or payable in connection with or in respect of any such amounts) arising out of or in connection with any Proceeding; provided that the term “Liabilities” shall not include any Expenses.

 “Person” means an individual, corporation, partnership, limited liability company, association, trust or other entity or
organization. 
 “Proceeding” means any threatened, pending or completed action, suit or other proceeding (which shall
include an arbitration or other alternative dispute resolution mechanism or an inquiry, investigation or administrative hearing), whether civil, criminal, administrative or investigative in nature (including any appeal therefrom) and whether
instituted by or on behalf of the Company or any other party, in any such case in which Indemnitee was, is or may be involved as a party or otherwise by reason of any Corporate Status of Indemnitee or by reason of any action taken (or failure to
act) by Indemnitee or on Indemnitee’s part while serving in any Corporate Status (in each case, whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification or advancement of Expenses can be
provided under this Agreement), or any inquiry or investigation that Indemnitee in good faith believes might lead to the institution of any such action, suit or other proceeding, including, without limitation, any such action, suit or other
proceeding involving a federal or state statute, rule or regulation regulating the offer, sale or purchase of securities, securities brokers or dealers and/or investment companies or advisors; provided that the term “Proceeding”
shall not include an action, suit or other proceeding contemplated by Section 8.6(b), below. 
 (b) For the purposes of this Agreement:

 References to “director, officer, employee or agent” shall include a trustee, general partner, managing member, fiduciary
or board of directors’ committee member. 
 References to “serving at the request of the Company” shall include any
service as a director, officer, employee or agent of the Company or any other Enterprise which imposes duties on, or involves services by, such director, officer, employee or agent with 

  

 4 

 
respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed
to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the Company”. 
 References to “the fullest extent permitted by applicable law” shall include (i) to the fullest extent permitted by the DGCL as in
effect on the date of this Agreement, and (ii) to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify
its officers, directors, employees, and agents. 
 ARTICLE 2 
 SERVICES BY INDEMNITEE 
 2.1 Services by Indemnitee. Indemnitee
hereby agrees to serve or continue to serve as a director and/or executive officer of the Company, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed. 
 ARTICLE 3 
 INDEMNIFICATION

 3.1 General. 
 (a) Subject to the limitations set forth in Section 3.2, below, to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in the defense of any Proceeding or
any claim, issue or matter therein, the Company hereby agrees to and shall indemnify Indemnitee and hold Indemnitee harmless, to the fullest extent permitted by applicable law, from and against all Expenses actually and reasonably incurred by
Indemnitee or on Indemnitee’s behalf in connection therewith; unless the Company can prove in the adjudication or arbitration contemplated by Section 6.1, below, that Indemnitee did not act in Good Faith. If Indemnitee is successful, on
the merits or otherwise, as to one or more but less than all claims, issues or matters in any Proceeding, the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in
connection with each successfully resolved claim, issue or matter and any claim, issue or matter related to each such successfully resolved claim, issue or matter. For purposes of this Section 3.l(a), the termination of any Proceeding or any
claim, issue or matter in a Proceeding by dismissal, with or without prejudice, or in any manner other than by an adverse judgment against Indemnitee (including, without limitation, through a settlement of such Proceeding, claim, issue or matter,
with or without the payment of money, in which there has been no allegation of wrongdoing on the part of Indemnitee) shall be deemed to be a successful result as to such Proceeding, claim, issue or matter. 
 (b) Subject to the limitations set forth in Section 3.2, below, in cases to which Section 3.1(a), above, does not apply, the
Company shall indemnify Indemnitee and hold Indemnitee harmless, to the fullest extent permitted by applicable law, from and against any and all Expenses and Liabilities actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf
in 

  

 5 

 
connection with any Proceeding, unless the Company can prove in the adjudication or arbitration contemplated by Section 6.1, below, that Indemnitee did
not act in Good Faith. 
 (c) To the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a witness in
any Proceeding to which Indemnitee is not a party, the Company shall indemnify Indemnitee and hold Indemnitee harmless, to the fullest extent permitted by applicable law, from and against any and all Expenses actually and reasonably incurred by
Indemnitee or on Indemnitee’s behalf in connection therewith. 
 3.2 Exclusions. Notwithstanding any provision of this Agreement
to the contrary (including, without limitation, Section 3.1, above, and Section 4.1 and Section 8.6(b), below), the Company shall not be obligated under this Agreement to indemnify Indemnitee from or against any Liabilities or
Expenses incurred by Indemnitee, or to advance to Indemnitee any Expenses, in connection with: 
 (a) any claim made against
Indemnitee (i) for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company pursuant to Section 16(b) of the Exchange Act or similar provisions of state statutory law, or
common law, or (ii) for reimbursement to the Company of any bonus or other incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, in each case as required under the
Exchange Act; 
 (b) except for an action, suit or other proceeding contemplated by Section 8.6(b), below, any action,
suit or other proceeding (or part thereof) initiated by Indemnitee (including any such action, suit or other proceeding (or part thereof) initiated by Indemnitee against the Company or its directors, officers, employees, agents or other
indemnitees), unless (i) the Board authorized or consented in writing to the action, suit or other proceeding (or part thereof) prior to its initiation, or (ii) the Company provides the indemnification, in its sole discretion, pursuant to
the powers vested in the Company under applicable law; 
 (c) any claim, issue or matter in a Proceeding by or in the right of
the Company to procure a judgment in its favor as to which Indemnitee shall have been adjudged to be liable to the Company unless and only to the extent the Delaware Chancery Court or the court in which such Proceeding was brought shall determine
upon application that, despite the adjudication of liability but in view of all circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such Expenses which the Delaware Chancery Court or such other court shall deem
proper. 
 ARTICLE 4 
 ADVANCEMENT OF EXPENSES; DEFENSE OF CLAIMS 
 4.1 Advances. The Company shall advance any Expenses incurred by
Indemnitee or on Indemnitee’s behalf in connection with a Proceeding within twenty (20) days after receipt by the Company of a written request for advancement of Expenses, which request 

  

 6 

 
may be delivered to the Company at such time and from time to time as Indemnitee deems appropriate in Indemnitee’s sole discretion (whether prior to or
after final disposition of any such Proceeding). Advances shall be made without regard to Indemnitee’s ability to repay such amounts and without regard to Indemnitee’s ultimate entitlement to indemnification under this Agreement or
otherwise. Any such advances shall be made on an unsecured basis and be interest free. 
 4.2 Repayment of Advances or Other Expenses.
Indemnitee hereby agrees to reimburse the Company for all amounts advanced by the Company pursuant to Section 4.1, above, if it is ultimately determined that Indemnitee is not entitled hereunder to be indemnified by the Company for such
Expenses. Notwithstanding the foregoing, if Indemnitee seeks a judicial adjudication or an arbitration pursuant to Section 6.1(a), below, Indemnitee shall not be required to reimburse the Company pursuant to this Section 4.2 until a final
determination (as to which all rights of appeal have been exhausted or lapsed) has been made. 
 4.3 Defense of Claims. 
 (a) The Company will be entitled to participate in the defense of any Proceeding at its own expense. The Company will not settle any
Proceeding (in whole or in part) which would impose any Expense, Liability or limitation on Indemnitee without Indemnitee’s prior written consent, such consent not to be unreasonably withheld, and, where applicable, without the consent of the
Company’s D&O Insurance carrier(s). 
 (b) Indemnitee will not settle any Proceeding (in whole or in part) which
would impose any Expense, Liability or limitation on the Company without the Company’s prior written consent, such consent not to be unreasonably withheld, and, where applicable, without the consent of the Company’s D&O Insurance
carrier(s). 
 (c) Notwithstanding the provisions set forth in Section 4.3(a) and Section 4.3(b), above, the defense
of any Proceeding shall be conducted in all respects in accordance with the terms of the Company’s D&O Insurance policies in effect at the time such Proceeding takes place. 
 ARTICLE 5 
 PROCEDURES FOR NOTIFICATION OF AND DETERMINATION OF 

ENTITLEMENT TO INDEMNIFICATION 
 5.1
Request for Indemnification. 
 (a) Indemnitee shall notify the Company in writing as soon as reasonably practicable
(i) after being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding, or (ii) if the Company has not been previously notified, after receipt of written notice of any
other matter with respect to which Indemnitee intends to seek indemnification or advancement of Expenses under Section 3.1 or Section 4.1, above. The omission by Indemnitee to so notify the Company will not relieve the Company from any
liability which it may have to Indemnitee (A) under this Agreement, except and only to the extent the Company can establish that such omission to notify resulted in actual material prejudice to the Company, or (B) otherwise than under this
Agreement. 
  

 7 

 (b) Indemnitee may thereafter deliver to the Company a written request for
indemnification pursuant to this Agreement at such time and from time to time as Indemnitee deems appropriate in Indemnitee’s sole discretion, which request shall also be deemed a request for advancement of Expenses under Section 4.1,
above. 
 5.2 Determination of Entitlement. 
 (a) Except as otherwise provided pursuant to Section 3.l(a) or Section 3.l(c), above, upon the final disposition of the matter
that is the subject of the request for indemnification delivered pursuant to Section 5.1(b), above, a determination shall be made with respect to Indemnitee’s entitlement thereto in the specific case. If a Change in Control shall
not have occurred, then such determination shall be made (i) by a majority vote of the Disinterested Directors or of a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors (in either case,
even if representing less than a quorum of the Board), or (ii) if there are no Disinterested Directors or the Disinterested Directors so direct, by Independent Counsel. If a Change in Control shall have occurred, then such determination shall
be made by Independent Counsel. Any determination made by Independent Counsel pursuant to this Section 5.2(a) shall be in the form of a written opinion to the Board, a copy of which shall be delivered to Indemnitee. Indemnitee shall reasonably
cooperate with the Person or Persons making such determination, including providing to such Person or Persons upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which
is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including fees and expenses of counsel) actually and reasonably incurred by Indemnitee in so cooperating with the person or persons making
such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification), and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. 
 (b) If the determination with respect to Indemnitee’s entitlement to indemnification hereunder is to be made by Independent Counsel,
then such Independent Counsel shall be selected as provided in this Section 5.2(b). If a Change in Control shall not have occurred, then the Independent Counsel shall be selected by the Board, and the Company shall give written notice to
Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected within ten (10) days after the final disposition of the matter that is the subject of the request for indemnification. If a Change in Control shall have
occurred, then the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the
Company advising it of the identity of the Independent Counsel so selected. In either case, the party receiving the notice may, within ten (10) days after receipt thereof, deliver to the other party a written objection to such selection;
provided that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as 

  

 8 

 
defined in Article 1 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely
objection, the Person so selected shall act as Independent Counsel. If a proper and timely objection is made, the counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction
(or, at Indemnitee’s option pursuant to Section 6.1, below, an arbitration) has determined that such objection is without merit. If, within ten (10) days after receipt by the Company of a request for indemnification pursuant to
Section 5.1(b), above, no Independent Counsel shall have been selected and not objected to, then either the Company or Indemnitee may petition a court of competent jurisdiction (or, at Indemnitee’s option pursuant to Section 6.1,
below, an arbitration) for resolution of any objection which shall have been made to the selection of Independent Counsel and/or for the appointment of another Person as Independent Counsel, and the Person with respect to whom all objections are so
resolved or the Person so appointed shall act as Independent Counsel. The Company agrees to pay the reasonable fees and expenses of any Independent Counsel appointed pursuant to this Section 5.2(b) and to indemnify such Person against any and
all expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto except for gross negligence or willful misconduct. 
 (c) If it is determined that Indemnitee is entitled to indemnification, then payment to Indemnitee shall be made within twenty
(20) days after such determination. 
 5.3 Presumptions and Burdens of Proof; Effect of Certain Proceedings. 
 (a) In making any determination as to Indemnitee’s entitlement to indemnification hereunder, Indemnitee shall be entitled to a
presumption that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 5.1(b), above, and the Company shall have the burden of coming forward with
evidence and the burden of persuasion by a preponderance of the evidence to overcome that presumption. 
 (b) The termination
of any Proceeding or of any claim, issue or matter therein by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not of itself create a presumption (i) that Indemnitee did not act in Good
Faith, or (ii) that Indemnitee did not otherwise satisfy the applicable standard of conduct to be indemnified pursuant to this Agreement. 
 (c) For purposes of any determination of Good Faith, Indemnitee shall be deemed to have acted in Good Faith if Indemnitee’s action is based on the records or books of account of the Company or other Enterprise,
as applicable, including financial statements, or on information supplied to Indemnitee by the officers of such entity in the course of their duties, or on the advice of legal counsel for such entity or on information or records given or reports
made to such entity by an independent certified public accountant, appraiser or other expert selected with reasonable care by such entity. The provisions of this Section 5.3(c) shall not be deemed to be exclusive or to limit in any way other
circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct to be indemnified pursuant to this Agreement. 
  

 9 

 (d) The knowledge or actions or failure to act of any other director, officer, employee
or agent of the Company or other Enterprise, as applicable, shall not be imputed to Indemnitee for purposes of determining Indemnitee’s right to indemnification under this Agreement. 
 (e) If a determination as to Indemnitee’s entitlement to indemnification shall not have been made pursuant to this Agreement within
sixty (60) days after the final disposition of the matter that is the subject of the request for indemnification, then the requisite determination of entitlement to indemnification shall be deemed to have been made in favor of Indemnitee, and
Indemnitee shall be entitled to such indemnification, absent a misstatement of a material fact in the information provided by Indemnitee pursuant to Section 5.1(b) and Section 5.2(a), above, or an omission of a material fact necessary in
order to make the information provided not misleading; provided that such sixty (60) day period will be extended for a period of up to an additional thirty (30) days after the selection of Independent Counsel pursuant to
Section 5.2(b), above, if such determination is to be made by Independent Counsel and if the Company has acted with diligence and in good faith in the process of selecting Independent Counsel; and provided, further, that such sixty
(60) day period (as so extended, if applicable) may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the Person or Persons making the determination in good faith requires such additional time to obtain or
evaluate any documentation or information relating thereto.  
 ARTICLE 6 
 REMEDIES OF INDEMNITEE 
 6.1
Adjudication or Arbitration. 
 (a) Indemnitee shall be entitled to an adjudication (by a court of competent
jurisdiction or, at Indemnitee’s option, through an arbitration conducted by a panel of arbitrators in accordance with the provisions of Section 6.1(c), below) of any determination pursuant to Section 5.2, above, that Indemnitee is
not entitled to indemnification under this Agreement. Any such adjudication shall be conducted in all respects as a de novo trial or arbitration on the merits, and any prior adverse determination shall not be referred to or introduced into evidence,
create a presumption that Indemnitee is not entitled to indemnification or advancement of Expenses, be a defense or otherwise adversely affect Indemnitee. In any such judicial proceeding or arbitration, the provisions of Section 5.3, above
(including the presumption in favor of Indemnitee and the burdens on the Company) shall apply. 
 (b) Indemnitee shall also be
entitled to an adjudication (by a court of competent jurisdiction or, at Indemnitee’s option, through an arbitration as described above and conducted in accordance with Section 6.1(c), below) of any other disputes under this Agreement.

  

 10 

 (c) Any arbitration conducted pursuant to Section 6.1(a) or Section 6.1(b),
above, shall consist of a panel of three (3) arbitrators selected from the panels of arbitrators of the International Institute for Conflict Prevention and Resolution (the “IICPR”), such panel to be presiding in Madison,
Wisconsin, consisting of (i) one (1) arbitrator selected by a majority vote of a quorum of the Board consisting of Disinterested Directors or, if a quorum of the Board consisting of Disinterested Directors cannot be obtained, by a majority
vote of a committee duly appointed by the Board and consisting solely of one or more Disinterested Directors, or, if unable to obtain such a quorum or form such a committee, by a majority vote of the full Board of Directors, including directors who
are parties to the same or related Proceedings, (ii) one (1) arbitrator selected by Indemnitee, and (iii) one (1) arbitrator selected by the two (2) arbitrators previously selected. In all other respects, the panel of
arbitrators shall be governed by the rules of the IICPR for non-administered arbitration (revised and effective June 15, 2005). Directors who are parties to the same or related Proceedings may participate in the designation of the member or
members of the committee referred to in this Section 6.1(c). 
 (d) If a determination shall have been made pursuant to
Section 5.2, above, that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 6.1, absent a misstatement of a material fact
in the information provided by Indemnitee pursuant to Section 5.1(b) and Section 5.2(a), above, or an omission of a material fact necessary in order to make the information provided not misleading. 
 (e) In connection with any judicial proceeding or arbitration commenced pursuant to this Section 6.1, the Company shall not oppose
Indemnitee’s right to seek such adjudication, shall be precluded from asserting that the procedures and presumptions of this Agreement are not valid, binding or enforceable and shall stipulate in any such court or before any such arbitrator
that the Company is bound by all of the provisions of this Agreement. 
 ARTICLE 7 
 DIRECTORS’ AND OFFICERS’ LIABILITY INSURANCE 
 7.1 D&O Insurance. 
 (a) The Company shall obtain and maintain a policy or
policies of insurance with reputable insurance companies providing liability insurance for directors and officers of the Company in their capacities as such (and for any capacity in which any director and/or officer of the Company serves any other
Enterprise at the request of the Company), in respect of acts or omissions occurring while serving in such capacity (“D&O Insurance”), on terms with respect to coverage and amount (including with respect to the payment of
expenses) no less favorable than those of such policy or policies in effect on the date hereof except for any changes approved by the Board prior to a Change in Control, which changes apply equally to all directors and officers of the Company. The
Company’s obligation to provide D&O Insurance coverage for Indemnitee pursuant to this Section 7.1 shall continue after the termination, for whatever reason, of Indemnitee’s appointment as a director and/or executive officer of
the Company, as the case may be. 
  

 11 

 (b) Indemnitee shall be covered by the Company’s D&O Insurance policy or
policies as in effect from time to time in accordance with the applicable terms to the maximum extent of the coverage available for any other director and/or executive officer under such policy or policies. The Company shall, promptly after
receiving notice of a Proceeding as to which Indemnitee is a party or a participant (as a witness or otherwise), give notice of such Proceeding to the insurers under the Company’s D&O Insurance policy or policies in accordance with the
procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable actions to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the
terms of such policy or policies. The failure or refusal of any such insurer to pay any such amount shall not affect or impair the obligations of the Company under this Agreement. Indemnitee shall not knowingly take any action that jeopardizes or
otherwise waives any coverage under any of the Company’s D&O Insurance policies then in effect. 
 (c) Upon request
by Indemnitee, the Company shall provide to Indemnitee copies of the D&O Insurance policy or policies as in effect from time to time. The Company shall promptly notify Indemnitee of any material changes in such insurance coverage. 
 ARTICLE 8 
 MISCELLANEOUS

 8.1 Nonexclusivity of Rights. The rights of indemnification and advancement of Expenses provided by this Agreement shall not be
deemed exclusive of any other rights to which Indemnitee may at any time be entitled to under applicable law, the Company’s certificate of incorporation or bylaws, any other agreement to which Indemnitee is a party, any vote of the
Company’s stockholders or resolution of the Company’s directors or otherwise, nor shall the rights hereunder be deemed a substitute for or diminish the rights of Indemnitee thereunder. No amendment, alteration or repeal of this Agreement
or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. To the
extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under this Agreement, it is the intent of the parties hereto that Indemnitee
shall be entitled under this Agreement to the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every right and remedy shall be cumulative and in addition
to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder or otherwise shall not prevent the concurrent assertion or employment of any
other right or remedy. 
  

 12 

 8.2 Subrogation, etc. 
 (a) In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights
of recovery of Indemnitee, who shall execute all papers required and take all actions necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. 
 (b) The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable hereunder (or for which
advancement is provided hereunder) if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise. 
 (c) The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the
Company as a director, officer, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such Enterprise. 
 8.3 Contribution. To the fullest extent permitted by applicable law, if the indemnification provided for in this Agreement is unavailable to
Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee or on Indemnitee’s behalf, whether for Liabilities and/or Expenses in connection with a Proceeding or
other expenses relating to an indemnifiable event or transaction under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such action, suit or other proceeding in order to reflect (a) the
relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving rise to such action, suit or other proceeding, and/or (b) the relative fault of the Company (and its directors, officers,
employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s). 
 8.4 Amendment. This Agreement may not
be modified or amended except by a written instrument executed by or on behalf of each of the parties hereto. 
 8.5 Waiver of Breach.
The observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument signed by the party against which such waiver is to be asserted. Unless
otherwise expressly provided herein, no delay on the part of any party hereto in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any party hereto of any right, power or
privilege hereunder operate as a waiver of any other right, power or privilege hereunder nor shall any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other
right, power or privilege hereunder. 
  

 13 

 8.6 Expenses. 
 (a) The Company shall pay all costs and expenses (including fees and expenses of counsel) actually and reasonably incurred by the Company
and Indemnitee in connection with the preparation or negotiation of this Agreement. 
 (b) Subject to the limitations set
forth in Section 3.2, above, the Company shall indemnify and hold Indemnitee harmless from and against any and all costs and expenses (including fees and expenses of counsel) actually and reasonably incurred by Indemnitee or on
Indemnitee’s behalf in seeking (whether through a judicial proceeding or arbitration (including any appeal resulting therefrom) or otherwise) to enforce any rights against the Company for indemnification or advancement of Expenses (whether
under this Agreement or otherwise) or to recover under any liability insurance policy maintained by any Person for the benefit of Indemnitee in connection with the performance of Indemnitee’s duties for or on behalf of the Company, in each
case, whether or not Indemnitee is successful (in whole or in part) with respect to Indemnitee’s claims. The Company shall pay (or reimburse Indemnitee for the payment of) any such costs or expenses within twenty (20) days after receipt by
the Company of a written request for the payment of such amounts, which request may be delivered to the Company at such time or from time to time as Indemnitee deems appropriate in Indemnitee’s sole discretion (whether prior to or after final
disposition of any such matter). Indemnitee shall have no obligation to reimburse any amounts paid by the Company pursuant to this Section 8.6(b). 
 8.7 Entire Agreement. This Agreement constitutes the entire agreement between the parties hereto with respect to the matters covered herein and supersedes all prior oral or written understandings or agreements
with respect to the matters covered herein. This Section 8.7 shall not be construed to limit any other rights Indemnitee may have under the Company’s certificate of incorporation or bylaws, applicable law or otherwise. 
 8.8 Partial Invalidity. If any provision of this Agreement shall be deemed invalid or inoperative, or if a court of competent jurisdiction
determines that any of the provisions of this Agreement contravene public policy, this Agreement shall be construed so that the remaining provisions shall not be affected but shall remain in full force and effect, and any such provisions which are
invalid or inoperative or which contravene public policy shall be deemed, without further action or deed by or on behalf of the Company or Indemnitee, to be modified, amended and/or limited, but only to the extent necessary to render the same valid
and enforceable. 
 8.9 Notices. All notices or other communications required or permitted to be given hereunder shall be in writing
and shall be considered to be given and received in all respects (a) when hand delivered, (b) one (1) business day after being sent by prepaid express or courier delivery service, (c) when sent by facsimile transmission actually
received by the receiving equipment with written confirmation thereof, or (d) three (3) days after being deposited in the United States mail, certified mail, postage prepaid, return receipt requested (provided that if there is a
general delay in mail delivery when the notice is mailed due to terrorism or other unusual circumstances, then the notice shall be considered to be given hereunder when it is actually received by the addressee), in each case addressed as follows, or
to such other address as shall be designated by like notice duly given: 
  

 14 

							
	IF TO THE COMPANY:	  	NimbleGen Systems, Inc.	  		  	
		  	One Science Court	  		  	
		  	Madison, WI 53711	  		  	
		  	Attention: Stanley D. Rose	  		  	
		  	Facsimile: (608) 218-7601	  		  	
				
	with a copy to:	  	Godfrey & Kahn, S.C.	  		  	
		  	780 North Water Street	  		  	
		  	Milwaukee, Wisconsin 53202	  		  	
		  	Attention: Kenneth C. Hunt	  		  	
		  	Facsimile: (414) 273-5198	  		  	
				
	IF TO INDEMNITEE:	  	  
	  		  	
		  	  
	  		  	
		  	  
	  		  	
		  	Facsimile:                                     
                           	  		  	

 8.10 Assignment; Binding Effect. 
 (a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in
order to induce Indemnitee to serve as a director and/or executive officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director and/or executive officer of the Company. Due to the
personal nature of the services to be rendered by Indemnitee, Indemnitee may not assign this Agreement. 
 (b) This Agreement
shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective heirs, legal representatives, successors and permitted assigns, including, with respect to the Company, any direct or indirect successor,
by purchase, merger, consolidation or otherwise, to all or substantially all of the business and/or assets of the Company. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise)
to all or substantially all of the business or assets of the Company, by written agreement in the form and substance reasonably satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the manner and to the same extent
that the Company would be required to perform if no such succession had taken place. 
 (c) The indemnification and
advancement of Expenses provided by this Agreement shall continue as to a person who has ceased to be a director and/or executive officer or is deceased and shall inure to the benefit of the heirs, executors, administrators or other successors of
the estate of such person. 
  

 15 

 8.11 Term of Agreement. This Agreement shall continue and terminate upon the later of (a) ten
(10) years after the date that Indemnitee shall have ceased to serve as a director and/or executive officer of the Company, or (b) the final termination of all pending Proceedings in respect of which Indemnitee is granted rights of
indemnification, contribution or allowance of Expenses hereunder. 
 8.12 Governing Law; Consent to Jurisdiction. This Agreement and
the legal relations among the parties hereto shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its choice of law or conflicts of law principles. Except with respect to any
arbitration commenced by Indemnitee pursuant to Section 6.1, above, the Company and Indemnitee hereby irrevocably and unconditionally (a) agree that any action, suit or other proceeding arising out of or in connection with this Agreement
shall be brought only in the Delaware Chancery Court and any court to which an appeal may be taken in such action, suit or other proceeding (the “Delaware Court”), and not in any other state or federal court in the United States of
America or any court in any other country, (b) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action, suit or other proceeding arising out of or in connection with this Agreement, (c) waive any
objection to the laying of venue of any such action, suit or other proceeding in the Delaware Court, and (d) waive, and agree not to plead or to make, any claim that any such action, suit or other proceeding brought in the Delaware Court has
been brought in an improper or inconvenient forum. 
 8.13 Headings. The Article and Section headings in this Agreement are for
convenience of reference only, and shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof. 
 8.14
Counterparts; Facsimile Copy. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such
counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement. This Agreement may be executed in facsimile copy with the same binding effect as the original. 
 8.15 Use of Certain Terms. As used in this Agreement, the words “herein,” “hereof” and “hereunder” and other words
of similar import refer to this Agreement as a whole and not to any particular paragraph, subparagraph, section, subsection or other subdivision. Whenever the context may require, the singular form of nouns, pronouns and verbs shall include the
plural and vice versa. 
 8.16 Effectiveness of Agreement. The Company and
Indemnitee hereby acknowledge and agree that this Agreement shall become effective only upon the final consummation of the IPO. In the event the IPO is not consummated in full on or before the ninetieth (90th) day after the date first set forth above, the parties hereto agree that this Agreement shall immediately be null and void and of no further
force and effect. 
  

 16 

 8.17 Legal Representation. This Agreement has been drafted by Godfrey & Kahn, S.C. as
counsel for the Company. Indemnitee hereby acknowledges and agrees that: 
 (a) Godfrey & Kahn, S.C. has not
represented Indemnitee in any way in connection with this Agreement; 
 (b) A conflict may exist between Indemnitee’s
interests and the interests of the Company; and 
 (c) Indemnitee has been advised to seek advice of independent legal counsel
and has had the opportunity to do so. 
 The remainder of this page has been intentionally left blank. 
  

 17 

 IN WITNESS WHEREOF, this Agreement has been duly executed and delivered to be effective as of the day,
month and year first above written. 
  

					
	NIMBLEGEN SYSTEMS, INC.
			
	 By:
	 		 	  

		 		 	Stanley D. Rose, Ph.D.,
		 		 	President and Chief Executive Officer

					
	
	  

	Print Name:	 	  

  

 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00124-of-00352.parquet"}]]